Abide Therapeutics

An approach to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indica....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Abide Therapeutics plus 6038 other startups.

Learn More About Abide Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More